Toggle navigation
Home
Search
Services
Blog
Contact
About
Phase Iib Randomized, Placebo-Controlled Trial of an Nsaid for the Mod-261025140
Cleveland Clinic Lerner, Cleveland, OH, United States
Search grants from Cleveland Clinic Lerner
Share this grant:
:
:
Abstract
Funding
Institution
Related projects
Comments
Recent in Grantomics:
Ohio State University
vs. funders. Who wins?
Read more...
How should you pick the next fundable research topic?
Read more...
Recently viewed grants:
Perceptual Learning and Memory Consolidation in Adults with and without Language Impairment
Deciphering the Treatment Risks: a Decision Support Tool for Transplant Candidates
The Influence of Binding and Crowding on Synaptic Protein Mobility
Physical Activity Enhancement in the Elderly
Interdisciplinary Neuroscience Training Program
Recently added grants:
Psychological and brain mechanisms underlying disparities in opioid and non-opioid pain treatment decisions
Single-molecule analysis of eukaryotic transcription activation
Effectivenss of an Integrated Treatment to Address Smoking Cessation and Anxiety/Depression in People Living with HIV
Reduction of intracochlear fibrosis and bacterial infection using photopolymerized durable zwitterionic coatings on cochlear implant biomaterials
High School Program in Biomedical and Health Sciences
Abstract
Funding Agency
Agency
National Institute of Health (NIH)
Institute
National Cancer Institute (NCI)
Type
Research and Development Contracts (N01)
Project #
N01CA025140-000
Application #
6688663
Study Section
Project Start
Project End
Budget Start
Budget End
Support Year
Fiscal Year
2002
Total Cost
Indirect Cost
Institution
Name
Cleveland Clinic Lerner
Department
Type
DUNS #
017730458
City
Cleveland
State
OH
Country
United States
Zip Code
44195
Related projects
NIH 2003
N01 CA
Phase Iib Randomized, Placebo-Controlled Trial of an Nsaid for the Mod-261025140
/ Cleveland Clinic Lerner
NIH 2002
N01 CA
Phase Iib Randomized, Placebo-Controlled Trial of an Nsaid for the Mod-261025140
/ Cleveland Clinic Lerner
Comments
Be the first to comment on this grant